期刊文献+

不同糖代谢水平动态血糖谱的差异 被引量:2

The variance of glucose profiles at different stages of glucose metabolism.
原文传递
导出
摘要 目的研究不同糖代谢水平血糖谱差异,以便指导干预时机的选择。方法对糖耐量正常(NGT)、空腹血糖受损(IFG)、餐后血糖受损(IGT)、IFG+IGT及新诊断T2DM患者的72小时动态血糖监测血糖谱进行分析。结果 IFG+IGT组血糖水平及血糖漂移显著高于NGT、IFG、IGT组(P<0.05)。新诊断T2DM组血糖水平显著高于NGT、IFG、IGT、IFG+IGT组(P均<0.05)。新诊断T2DM组餐后及日内血糖漂移与IFG+IGT组无显著差异(P>0.05)。结论 (1)随着糖代谢异常的加重,血糖水平升高,血糖漂移程度增加;(2)IFG+IGT阶段应积极干预。 Objective To investigate the variance of daily glucose profiles at different stages of glucose metabolism so as to instruct the development of rational programs of treatment. Methods The CGMS(continuous glucose monitoring sysytem)data of NGT(nomal glucose tolerance), IFG(impaired fasting glucose), IGT(impaired glucose tolerance) ,IFG+IGT and newly diagnosed T2DM(type 2 diabetes mellitus)were analyzed. Results There was no significant difference between NGT,IFG and IGT in the level of glucose and the degree of glycemic excursion(P〉0. 05). The level of glucose and the degree of glycemic excursion in IFG plus IGT were significantly higher than those in NGT, IFG and IGT(P〈 0.05). There was no significant difference between IFG plus IGT and T2DM in the degree of glyeemic excursion(P〉0. 05). The level of glucose in T2DM was significantly higher than that of other groups(P〈 0. 05). Conclusions With the aggravation of abnormality of glucose metabolism, the level of glucose becomes higher and the degree of glycemic excursion becomes more serious. Early intervention is suggested on the stage of IFG plus IGT.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第12期926-928,共3页 Chinese Journal of Diabetes
基金 南京市卫生局资助项目(YKK0447)
关键词 糖尿病 2型 空腹血糖受损 糖耐量受损 动态血糖监测系统 Diabetes mellitus, type 2 Impaired fasting glucose Impaired glucose tolerance Continuous glucose monitoring system
  • 相关文献

参考文献9

  • 1Meyer J, Sturis J, Katschinski M, et al. Acute hyperglycemia alters the ahility of the normal β-cell to sense and respond to glu cose. Am J Physiol Endocrinol Metah, 2002,282:E917-E922.
  • 2Guerra S, Grupillo M, Masini M, et al. Gliclazide protects human isletβ-cells from apoptosis induced by intermittent high glucose. Diabetes Metab Res Rev,2007,23:234-238.
  • 3Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab,1999,12:751-758.
  • 4Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther,2000,2:49-56.
  • 5喻明,周健,项坤三,陆惠娟,马晓静,陆蔚.动态监测糖耐量正常者血糖水平的漂移变化[J].中华医学杂志,2004,84(21):1788-1790. 被引量:50
  • 6喻明,周健,项坤三,李鸣,李青,周逸常.动态监测新诊断2型糖尿病患者的血糖水平[J].中华糖尿病杂志(1006-6187),2005,13(2):102-104. 被引量:87
  • 7DECODE Study Group in behalf of the European Diabetes Epidemiology Group. Age,body mass index and glucose tolerance in 11 European population-based surveys. Diabetic Medicine, 2002,19 : 558-565.
  • 8Scheen AJ, Letiexhe MR, Ernest P. Prevention of type 2 diabetes: lifestyle changes or pharmacological interventions? Medieale deliege, 2003,58: 206-210.
  • 9STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet, 2002,359 : 2072-2077.

二级参考文献18

  • 1Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther,2000,2:49-56.
  • 2Mastrototaro J. The MiniMed continuous glucose monitoring system(CGMS). J Pediatr Endocriol Metab, 1999,12:751-758.
  • 3Bode BW, Gross TM, Thornton KR, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin. Diabetes Res Clin Pract, 1999,46:183-190.
  • 4Boyne MS, Silver DM, Kaplan J, et al. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes, 2003, 52:2790-2794.
  • 5Steil GM, Rebrin K, Mastrototaro J, et al. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther,2003,5:27-31.
  • 6Kaufman FR, Carpenter S, Gibson LC, et al. A pilot study of the continuous glucose monitoring system. Diabetes Care, 2001,24:2030-2034.
  • 7Rohlfing CL, England JD, Wiedmeyer HM, et al. Defining the relationship between plasma glucose and HbA1c. Diabetes Care, 2002,25:275-278.
  • 8American Diabetes Association. Clinical practice recommendations. Diabetes Care,2001, 24(Suppl.1): 5-24.
  • 9World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
  • 10Mastrototaro J. The MiniMed continuous glucose monitoring system(CGMS). J Pediatr Endocriol Metab, 1999,12:751-758.

共引文献123

同被引文献10

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部